Abstract

Accurate measures of plasma FA oxidation can improve our understanding of diseases characterized by impaired FA oxidation. We describe and compare the 24 h time-courses of FA oxidation using bolus injections of [1-(14)C]palmitate versus [9,10-(3)H]palmitate under postabsorptive, postprandial, and walking conditions. Fifty-one men and 95 premenopausal women participated in one condition (postabsorptive, postprandial, or walking), one tracer ((14)C- or (3)H-labeled), and an acetate or palmitate study. Groups were matched for sex, age, and body mass index (BMI). At 24 h, cumulative [(3)H]acetate recovery as (3)H(2)O was 80 ± 6%, 78 ± 2%, and 81 ± 6% in the postabsorptive, postprandial, and walking conditions, respectively (not significant). Model-predicted maximum [1-(14)C]acetate recovery as expired (14)CO(2) was 59 ± 12%, 52 ± 8%, and 65 ± 10% in the postabsorptive, postprandial, and walking condition, respectively (one way ANOVA, P = 0.12). When corrected with the corresponding acetate recovery factors, 24 h time-courses of FFA oxidation were similar between [1-(14)C]palmitate and [9,10-(3)H]palmitate in all three conditions. In contrast to previous meal ingestion studies, an acetate-hydrogen recovery factor was needed to achieve comparable oxidation rates using an intravenous bolus of [(3)H]palmitate. In conclusion, intravenous boluses of [9,10-(3)H]palmitate versus [1-(14)C]palmitate gave similar estimates of 24 h cumulative FFA oxidation in age-, sex- and BMI-matched individuals.

Highlights

  • Accurate measures of plasma FA oxidation can improve our understanding of diseases characterized by impaired FA oxidation

  • The goals of the present study were 1) to describe and compare the 24 h time courses of cumulative FA oxidation assessed with a bolus injection of [1-14C]palmitate versus [9,10-3H]palmitate under three conditions: postabsorptive, postprandial, and during walking; and 2) to provide [1-14C]acetate and [3H]acetate recovery factors

  • Participants’ average age was between 30 and 40 years, average body mass index (BMI) fell into the overweight category, and percent body fat was ‫ف‬35%

Read more

Summary

Introduction

Accurate measures of plasma FA oxidation can improve our understanding of diseases characterized by impaired FA oxidation. We describe and compare the 24 h time-courses of FA oxidation using bolus injections of [1-14C]palmitate versus [9,10-3H]palmitate under postabsorptive, postprandial, and walking conditions. Intravenous boluses of [9,10-3H]palmitate versus [1-14C]palmitate gave similar estimates of 24 h cumulative FFA oxidation in age-, sex- and BMI-matched individuals.—Koutsari, C., A. FA tracers labeled on the carbon or hydrogen atoms are used for the study of plasma FFA oxidation in humans in. The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 1 UL1 RR-024150-01. To the best of our knowledge, there is no information on the use of carbonand hydrogen isotope-labeled FAs in studies where the FFA tracers are administered as intravenous injections. Being able to incorporate whole-body FFA oxidation data into bolus injection experiments may increase the value of such studies

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call